thiophenes has been researched along with Biliary Tract Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amoroso, V; Ferrari, VD; Fusi, A; Mambrini, A; Marini, G; Marpicati, P; Montini, E; Rangoni, G; Simoncini, E; Valcamonico, F; Vasalli, L | 1 |
| Barthélemy, P; Bennouna, J; Bourgeois, H; Dorval, E; Douillard, JY; François, E; Hebbar, M; Martin, C; Mayeur, D; Perrier, H | 1 |
2 trial(s) available for thiophenes and Biliary Tract Cancer
| Article | Year |
|---|---|
Epirubicin, cisplatin, and raltitrexed in patients with advanced gastric and hepatobiliary carcinoma: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Cisplatin; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Quinazolines; Stomach Neoplasms; Survival Analysis; Thiophenes | 2004 |
A phase II trial of raltitrexed (Tomudex) in advanced pancreatic and biliary carcinoma.
Topics: Antimetabolites, Antineoplastic; Biliary Tract Neoplasms; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Quality of Life; Quinazolines; Survival Rate; Thiophenes; Thymidylate Synthase; Treatment Outcome | 2005 |